Newsletter Archive

January 2008

Alzheimer’s Advocate vol. 2

Letter from the Chairman: Alzheimer’s Scientific Workshop and the FDA

FDA Science Board Calls for Increased Funding at the FDA

 

February 2008

Alzheimer’s Advocate vol. 3

AD Ally/FDA Scientific Workshop to Take Place March 13

FDA Advocacy Groups Call for Increase in FY09 Budgets

 

March 2008

Alzheimer’s Advocate vol. 4

Advocates and Regulators Come Together for AD Scientific Workshop

Release of Informational Alzheimer’s “Pocket” Films

New Coalition Member

 

April 2008

Alzheimer’s Advocate vol. 5

ACT-AD Urges Congress to Increase Funds for FDA

Alzheimer Research Forum Highlights AD Allies/FDA Scientific Workshop

IOM Focuses on Science at FDA and Patient Access to Treatments

 

May 2008

Alzheimer’s Advocate vol. 6

FDA Commissioner Calls for Immediate Funding to Modernize Agency

ACT-AD Chairman Presents at Dialogue on Diversity Health Care Symposium

Senate Committee Examines the Future of Alzheimer’s Disease

 

June 2008

Alzheimer’s Advocate vol. 7

$150 Million in Emergency FDA Funding Approved; 2009 Process Halted

 

July/August 2008

Alzheimer’s Advocate vol. 8

Congress Acts to Increase Funding for FDA

ACT-AD and the 11th Annual International Conference on Alzheimer’s Disease

Virtual Town Hall on Early Detection and Alzheimer’s Disease

 

September 2008

Alzheimer’s Advocate vol. 9

Prominent Clinicians Encourage FDA to Validate AD Biomarkers for Use in Clinical Trials

 

October 2008

Alzheimer’s Advocate vol. 10

FDA to Receive Additional Funding for FY 2009

New Coalition Member

 

November 2008

Alzheimer’s Advocate vol. 11

November is National Alzheimer’s Disease and Family Caregivers Awareness Month

Note from the Chairman

 

December 2008

Alzheimer’s Advocate vol. 12

A Look Back on 2008

 

January 2009

Alzheimer’s Advocate vol. 13

Daschle Remarks on FDA Leadership

NIA Progress Report and PBS Special Focus on Alzheimer’s Disease Research

 

February 2009

Alzheimer’s Advocate vol. 14

Editorial Examines the Need for Changes in Clinical Trials

Congress Acts on FY 2009 Funding for the Food and Drug Administration

Task Force Calls for Changes to National Institutes of Health Intramural Research Program

 

March 2009

Alzheimer’s Advocate vol. 15

Obama Administration Chooses New FDA Leadership

Progress Reported in Biomarker Tests for Alzheimer’s Disease

National Alzheimer’s Plan is Unveiled to Congress

 

April 2009

Alzheimer’s Advocate vol. 16

National Institute on Aging and HBO Produce Documentary on Alzheimer’s Disease

ACT-AD Welcomes New Corporate Sponsor

 

May 2009

Alzheimer’s Advocate vol. 17

New Funding and Leadership for the FDA

Campaign Launched to Urge Family Discussions about Alzheimer’s Disease

GQ and the Geoffrey Beene Alzheimer’s Initiative Honor “Rock Stars of Science”

 

June 2009

Alzheimer’s Advocate vol. 18

House Appropriations Committee Adopts Appropriations Bill Granting FDA Increased Funding

ACT-AD to Host Upcoming Scientific Workshop on Clinical Meaningfulness

 

July 2009

Alzheimer’s Advocate vol. 19

ACT-AD Hosts Second Scientific Workshop on Clinical Meaningfulness in Alzheimer’s Disease

2009 International Conference on Alzheimer’s Disease Sheds new Light on the Economic Burden of Alzheimer’s

 

August 2009

Alzheimer’s Advocate vol. 20

Bill Introduced to Create an Office of the National Alzheimer’s Project

Senate Passes bill for Fiscal Year 2010 Appropriations for the Food and Drug Administration (FDA)

 

September 2009

Alzheimer’s Advocate vol. 21

ACT-AD Survey Finds that Alzheimer’s is a National Priority among Voters

“Diagnosing Dementia: See it Sooner” the Theme for World Alzheimer’s Day 2009

Upcoming Event Hosted by ACT-AD Member FasterCures

 

October 2009

Alzheimer’s Advocate vol. 22

2009 National Memory Screening Day to be held November 17th

Food and Drug Administration 2010 Appropriations Signed Into Law

 

November 2009

Alzheimer’s Advocate vol. 23

Alzheimer’s Treatment and Caregiver Support Act Introduced in Congress

2009 National Memory Screening Day Promoted Alzheimer’s Disease Awareness

 

December 2009

Alzheimer’s Advocate vol. 24

A Look Back on 2009

 

January 2010

Alzheimer’s Advocate vol. 25

Outlook for the FDA Underscores the Need for Greater Investment in the Agency

ACT-AD Member Hosts 4th Annual Drug Discovery for Neurodegeneration Conference

 

February 2010

Alzheimer’s Advocate vol. 26

National Alliance for Caregiving to Present at 2010 “Aging in America” Conference

NIH to Host Conference on Preventing Alzheimer’s Disease and Cognitive Decline

 

March 2010

Alzheimer’s Advocate vol. 27

FDA to Hold Public Hearing on the Prescription Drug User Fee Act Reauthorization

ACT-AD Welcomes New Corporate Sponsor

ACT-AD Member to Host Symposium on Mitochondrial Function in Alzheimer’s

Upcoming Patient Advocacy Reception on Imaging

 

April 2010

Alzheimer’s Advocate vol. 28

ACT-AD Chair Makes Remarks on Prescription Drug User Fee Act Reauthorization

Patient Groups Seek Funding for New Cures Acceleration Network

 

May 2010

Alzheimer’s Advocate vol. 29

Poll Finds Strong Support for Collaboration on Research

ACT-AD Chair Stresses the Importance of Regulatory Science in Alzheimer’s Disease

Launch of New Alzheimer’s Clinical Trial Database

 

June 2010

Alzheimer’s Advocate vol. 30

FDA Continues Stakeholder Outreach on PDUFA Reauthorization

Public–Private Partnership Launches New Clinical Trial Database

 

July 2010

Alzheimer’s Advocate vol. 31

Congress Acts to Increase Funding for FDA

ACT-AD and the International Conference on Alzheimer’s Disease

 

September 2010

Alzheimer’s Advocate vol. 33

White House Highlights Alzheimer’s Disease Challenges

ACT-AD Member Hosts 8th Annual National Memory Screening Day

Notable Experts Join Launch of Alzheimer’s Disease Movement

 

October 2010

Alzheimer’s Advocate vol. 34

ACT-AD to Host Workshop on Streamlining Phase II Clinical Trials

Alzheimer’s and Aging Advocates Partner to Highlight NIA Research on Capitol Hill

AFA to Host 8th Annual National Memory Screening Day

 

Novemeber 2010

Alzheimer’s Advocate vol. 35

ACT-AD to Host Alzheimer’s Allies Meeting on Streamlining Phase II Trials

7 Summits Climb

GAO Appoints ACT-AD Member to CER Board

 

December 2010

Alzheimer’s Advocate vol. 36

Congress Passes Legislation to Establish a National Office on Alzheimer’s Disease

Advocates Meet with NIH Director on Urgent Need for Increased NIA Funding

 

January 2011

Alzheimer’s Advocate vol. 37

Filling the Gap

ACT-AD Chair Weighs in on AD Biomarkers at Advisory Committee Meeting

 

February 2011

Alzheimer’s Advocate vol. 38

President Releases FY2012 Budget

Highlights from the 5th Drug Discovery for Neurodegeneration Conference

 

March 2011

Alzheimer’s Advocate vol. 39

FDA Commissioner Testifies on FY2012 Budget

ACT-AD Member Unveils New Care Crossroads Website

Upcoming Reception on Imaging and Advances in Patient Care

 

April 2011

Alzheimer’s Advocate vol. 40

Congress Approves Increased Funding for FDA

CNN to Air Special on the Alzheimer’s Epidemic

 

May 2011

Alzheimer’s Advocate vol. 41

House Subcommittee Cuts Funding to FDA

 

June 2011

Alzheimer’s Advocate vol. 42

House Approves Funding Cuts to FDA

FDA, Industry, agree on PDUFA V

Congressional Briefing to be Held on Alzheimer’s and the Next Generation of Innovations and Therapies

 

July 2011

Alzheimer’s Advocate vol. 43

Commissioner Stresses the Importance of User Fees Before Senate Committee

FDA Center for Drug Evaluation and Research develops strategic science and research agenda

ACT-AD Chair speaks to BioCentury This Week about PDUFA V

 

August 2011

Alzheimer’s Advocate vol. 44

FDA Releases Regulatory Science Plan

HHS Announces NAPA Advisory Council Membership

The Alzheimer’s Drug Discovery Foundation to Host 12th International Conference on Alzheimer’s Drug Discovery

 

September 2011

Alzheimer’s Advocate vol. 45

Senate Committee Acts to Approve More Funds for FDA

ACT-AD to Host an Experts’ Dinner in San Diego

Alzheimer’s Advocate and Mountaineer Climbs Mt. Kilimanjaro in Honor of World Alzheimer’s Day

The Alzheimer’s Foundation of America to Host 9th Annual National Memory Screening Day

 

October 2011

Alzheimer’s Advocate vol. 46

ACT-AD to Hold Annual FDA/AD Allies Meeting on Phase II Trials

ACT-AD Chair Makes Remarks on Prescription Drug User Fee Program

New Alzheimer’s Disease Health Center Launches on VisualMD.com

Effort to Discover the Keys to Alzheimer’s Disease Continues

 

November 2011

Alzheimer’s Advocate vol. 47

ACT-AD to Hold Annual FDA/AD Allies Meeting on Phase II Trials

ACT-AD and the Clinical Trials on Alzheimer’s Disease Conference

ACT-AD Member Releases New Study on Caregiver Health

Congress Acts to Increase Funding for FDA

 

December 2011

Alzheimer’s Advocate vol. 48

ACT-AD Holds Annual FDA/AD Allies Meeting on Phase II Trials

Working Group of Experts Release Review on Biomarkers for Alzheimer’s Disease

ACT-AD Chair Speaks About Expedited Drug Pathways

 

January 2012

Alzheimer’s Advocate vol. 49

National Alzheimer’s Project Act Draft Framework Released

Congress to Hear Recommendations for User Fee Reauthorization

Alzheimer’s Challenge 2012 Introduced at Care Innovations Summit

ACT-AD Member Hosts 6th Drug Discovery for Neurodegeneration Conference

 

February 2012

Alzheimer’s Advocate vol. 50

PDUFA V Reauthorization Process Advances to Congress

Two-Year Bolus of Funding for Alzheimer’s Research Announced

NIA to Hold Alzheimer’s Disease Research Summit

 

March 2012

Alzheimer’s Advocate vol. 51

PDUFA V Reauthorization Update

ACT-AD Supports Increase in FDA Appropriations

ACT-AD Chair Speaks to BioCentury This Week About Alzheimer’s Funding and Biomarkers

 

April 2012

Alzheimer’s Advocate vol. 52

FDA FY 2013 Appropriations Update

User Fee Reauthorization Update

NAPA Advisory Council on Alzheimer’s Research, Care and Services, Releases Revised Draft National Plan to Address Alzheimer’s Disease

REMINDER: HHS and NIA to Hold Alzheimer’s Disease Research Summit

 

May 2012

Alzheimer’s Advocate vol. 53

User Fee Reauthorization Update

ACT-AD Represented at First-Ever FDA Patient Network Meeting on Risk-Benefit Analysis

NIA Holds Alzheimer’s Disease Research Summit

 

June 2012

Alzheimer’s Advocate vol. 54

User Fee Reauthorization Update

FDA Appropriations Update

NAPA to Hold Advisory Council Meeting Next Month

Winner of Alzheimer’s Challenge 2012 Announced

 

July/August 2012

Alzheimer’s Advocate vol. 55

User Fee Reauthorization Update

NAPA Holds July Advisory Council Meeting

ACT-AD Member Events

 

September 2012

Alzheimer’s Advocate vol. 56

ACT-AD to Hold Annual FDA/AD Allies Meeting on Combination Therapies and Pre-Competitive Collaboration

ACT-AD to Have a Presence at CTAD 2012

PhRMA Holds Inaugural Research and Hope Awards in Washington, DC

ACT-AD Chair Sends Letter to Congressional Leadership Concerning Sequester Cuts to FDA

Join ACT-AD and Its Allies in Spreading Congressional Petition to End Alzheimer’s Disease

 

October 2012

Alzheimer’s Advocate vol. 57

ACT-AD to Hold Annual FDA/AD Allies Meeting on Combination Therapies

NAPA Holds October Advisory Council Meeting

FDA Holds First Public Meeting on Patient-Focused Drug Development

The Alzheimer’s Foundation of America to Host 10th Annual National Memory Screening Day

 

November 2012

Alzheimer’s Advocate vol. 58

ACT-AD Represented at the 5th Clinical Trials in Alzheimer’s Disease Conference

ACT-AD Holds Annual FDA/AD Allies Meeting on Combination Therapies

ACT-AD Leads Advocacy Group Comments to FDA Regarding Patient-Focused Drug Development

 

January 2013

Alzheimer’s Advocate vol. 59

Redesigned ACT-AD.org Officially Launches

Advisory Council Meeting on National Alzheimer’s Plan Implementation

Sequester Delayed; Cuts Still Loom Over FDA

Galien Forum Features Panel on Alzheimer’s Disease

 

February 2013

Alzheimer’s Advocate vol. 60

Sequester Cuts Loom Large at FDA

Series Features ACT-AD Meeting on Combination Therapies

ACT-AD Chair Quoted by BioCentury on FDA Retirement and AD Guidance

 

March 2013

Alzheimer’s Advocate vol. 61

NIH to Hold Alzheimer’s Disease-Related Dementias Research Conference

FDA Clarifies Guidance on Early Stage Alzheimer’s Therapy Approval

SAVE THE DATE: May 28-30, 2013 ACT-AD Expert Consensus Retreat on Combination Therapies

 

April 2013

Alzheimer’s Advocate vol. 62

ACT-AD to Hold Expert Consensus Retreat on Combination Therapies

ACT-AD Weighs In on FDA Guidance on Early AD Development

Alzheimer’s Research Would Get $80 Million Increase Under Obama’s 2014 Budget

 

May 2013

Alzheimer’s Advocate vol. 63

ACT-AD Hosts Multi-Day Expert Retreat on Combination Therapies

NIH Director Defends Budget Increase in the Senate

NIH Holds Summit on Alzheimer’s Disease-Related Dementias

ACT-AD Member to Host 14th Annual International Conference on Alzheimer’s Drug Discovery

 

June 2013

Alzheimer’s Advocate vol. 64

ACT-AD Meeting on Combination Therapies Featured in the Alzheimer Research

ACT-AD Supports National Memory Screening Day

Congress Acts on FY 2014 Funding for the FDA

HHS Releases Revised National Plan to Address Alzheimer’s Disease

ACT-AD Member Hosts Women’s Health Research Conference

Critical Path Institute Marks Milestone Regulatory Decision

 

July 2013

Alzheimer’s Advocate vol. 65

Bipartisan Bill Exempting FDA User Rees from Sequestration Introduced in House

National Institute on Aging Debuts Database for Cognitive Impairment Screening Tools

AFA Accepting Nominations for 2013 Dementia Care Professional of the Year Award

The Alzheimer’s Foundation of America to Host 11th Annual National Memory Screening Day

 

August/September 2013

Alzheimer’s Advocate vol. 66

FDA to Hold Annual Second Patient Network Meeting

ACT-AD Sends Letters of Support for Bipartisan Bills Protecting FDA User Fees from Sequester

ACT-AD Member to Host 14th Annual International Conference on Alzheimer’s Drug Discovery

 

October 2013

Alzheimer’s Advocate vol. 67

Senator Jerry Moran Pens Alzheimer’s Editorial

FDA Backlogged After Shutdown

PhRMA Addresses Alzheimer’s Therapy Development

New York Academy of Science to Host Alzheimer’s Summit

 

November 2013

Alzheimer’s Advocate vol. 68

ACT-AD Has a Presence at CTAD 2013

FDA User Fees Get Congressional Support

Alzheimer’s Foundation of America Hosts 11th Annual National Memory Screening Day

Alzheimer’s Foundation of America and the National Alliance for Caregiving to Hold Conference on NAPA Implementation

Alzheimer’s Registry to Aid in Clinical Trial Recruitment

 

December 2013

Alzheimer’s Advocate vol. 69

Congressional Budget Deal to Ease Strain on FDA

NIH Deposits First Batch of Genomic Data for Alzheimer’s Disease Database

ACT-AD Advisory Council Members Hold Caregiver Conference on National Alzheimer’s Plan

ACT-AD Member Hosts 8th Drug Discovery for Neurodegeneration Conference

January 2014

Alzheimer’s Advocate vol. 70

FDA Fares Well in FY 2014 Appropriations

NAPA Advisory Council to Hold First Meeting of 2014

Academy of Radiology Research Sets Date for Postponed Conference on Brain Imaging Advances

ACT-AD Member Hosts 8th Drug Discovery for Neurodegeneration Conference

February 2014

Alzheimer’s Advocate vol. 71

FDA and IOM Examine Risk-Benefit Communication

Accelerating Medicines Partnerships Launches to Speed Drug Development

Academy of Radiology Research Holds Conference on Brain Imaging Advances

Beginning with the End in Mind – Study Endpoints: Targeting Patient-Centered Outcomes

March 2014

Alzheimer’s Advocate vol. 72

FDA to Examine Inclusion of Subpopulations in Clinical Trials

Health Affairs: The Long Reach of Alzheimer’s Disease

NIBIB Director to Host Seminar on Technological Advances

ACT-AD Chair to Screen Pocket Films at French Embassy

GE Launches MIND App for Patients and Caregivers

April 2014

Alzheimer’s Advocate vol. 73

ACT-AD Member Announces $8.7 Million in Research Grants for Alzheimer’s and Vision Diseases

Coalition Sponsors Health Affairs Special Issue on Alzheimer’s Disease

ACT-AD Chair Holds Successful Screening of ‘Pocket Films’ at French Embassy

CMS National Partnership to Improve Dementia Care in Nursing Homes Holds Call on May 20

7th Annual FDA/Alzheimer’s Disease Allies Meeting Set for November 6

May 2014

Alzheimer’s Advocate vol. 74

2014 National Alzheimer’s Disease Plan Released

Alzheimer’s Foundation of America Releases Report

Aging Research at the National Institute on Aging Briefing June 6

Neuroscience and Aging Discussion September 10 in Washington, D.C.th

Annual FDA/Alzheimer’s Disease Allies Meeting Set for November 6


June 2014

Alzheimer’s Advocate vol. 75

Volunteers Requested for Alzheimer’s Clinical Trials

Scientists Map Path of Alzheimer’s-Linked Brain Cells in Mouse Models

Project Lifesaver International Holds Annual Conference This August

ACT-AD Responds to 21st Century Cures White Paper

Study Reveals Possible Novel Therapy for Alzheimer’s

Memory in Old Age May Be Affected by History of High Blood Pressure

$4.5 Billion Brain Research Report Receives Positive Response from NIH

Annual FDA/Alzheimer’s Disease Allies Meeting Set for November 6


July 2014

Alzheimer’s Advocate vol. 76

Webinar Series on Alzheimer’s Disease and Related Dementias Launches

2013-2014 Alzheimer’s Disease Progress Report Now Available

National Memory Screening Day Is November 18

Path to Fund Development of Alzheimer’s Drugs Suggested

NIH Sends Out Call for Participants for A4 Clinical Trial

2014 Alzheimer’s Association International Conference Resources Available

7th Annual FDA/Alzheimer’s Disease Allies Meeting Set for November 6


August 2014

Alzheimer’s Advocate vol. 77

ACT-AD FDA/AD Allies Meeting Proceedings to Be Featured inExpert Review of Neurotherapeutics

FDA PDUFA V Plan on Demographic Data Released

AFA Caregiver Conference Set for September 12

Alzheimer’s Prevention Registry Adds 40,000th Volunteer

AARP and ReACT Host Caregiver Event, September 29

Study Shows Link between DNA Methylation and Alzheimer’s

Researchers Find Area in Brain Associated with Contextual Memories

7th Annual FDA/Alzheimer’s Disease Allies Meeting Set for November 6


 

September 2014

Alzheimer’s Advocate vol. 78

Positive Trial Results Reported for Treatment of Agitation

RSVP for 7th Annual FDA/Alzheimer’s Disease Allies Meeting

NIA Offers Alzheimer’s Medications Fact Sheet

2014 World Alzheimer’s Day Recognized

Bexarotene’s Effect on Alzheimer’s May Be Dependent on Disease Severity

Study Shows Link between DNA Methylation and Alzheimer’s

Study Offers New Insights of Buildup of Beta-Amyloid Plaques in Brain


October 2014

Alzheimer’s Advocate vol. 79

RSVP for 7th Annual FDA/Alzheimer’s Disease Allies Meeting

APECS Study Seeks Participants

Scientists Create ‘Alzheimer’s in a Dish’

Registration Now Open for 2015 NIH Alzheimer’s Disease Research Summit

Alzheimer’s May Erase Memories, But Emotions Often Remain, Finds Study

MRI Technique Reveals Cognitive Decline before Symptoms Appear

Researchers Use Large Data Collection to Find New Gene Linked to AD


November 2014

Alzheimer’s Advocate vol. 80

ACT-AD Holds 7th Annual FDA/Alzheimer’s Disease Allies Meeting

Updates of Note from NIH, CDC, Other Agencies

Organization Releases Trend Report of Antipsychotic Drug Use

New Neurological Disorder Has Links to Alzheimer’s

Conference on Drug Discovery for Neurodegeneration Set for March 1-3, 2015

Study Finds Tau, Not Amyloid-Beta Plaque,Causes Neuron Death

Growth of Older Population to Drive Higher Alzheimer’s Costs


December 2014

Alzheimer’s Advocate vol. 81

ACT-AD Submits Comments on FDA PDUFA V Initiative

ACT-AD Offers Insights on Aging Well in 21st Century

ACT-AD Science Advisory Board Member Gives Keynote Address at CTAD Conference

Psoriasis Drug Could Stimulate Alzheimer’s-Fighting Enzyme

NIH Issues Draft Policy Promoting IRBs

Study: Midlife Diabetes Accelerates Rate of Cognitive Decline

Keeping Microglia ‘On the Job’ Could Ward Off Alzheimer’s


January 2015

Alzheimer’s Advocate vol. 82

ACT-AD Meeting on Combination Therapy Featured in Expert Review of Neurotherapeutics

Volunteers Can Make a Difference for Alzheimer’s Research

ACT-AD Sterling Silver Sponsor of February NIH Alzheimer’s Research Summit

Pat Summitt Alzheimer’s Clinic to Open in Tennessee

New MRI Technique Detects Early Alzheimer’s

Insulin Spray May Improve Memory in Dementia Patients

Issues Related to Heart and Stroke Contribute to Dementia


February 2015

Alzheimer’s Advocate vol. 83

Q & A with Anavex President and CEO Missling

ACT-AD Responds to 21st Century Cures Legislation

NIH Alzheimer’s Research Summit Available for Viewing

ACT-AD Meeting on Combination Therapy Featured in Expert Review of Neurotherapeutics

‘SuperAgers’ Research Could Offer Hope for Alzheimer’s Patients

Conversation with FDA Commissioner Dr. Margaret Hamburg

Dietary Advanced Glycation End Products Could Increase Alzheimer’s Risk, Says Study

Alzheimer’s Association Releases New Report on AD Trajectory

‘Rebalancing’ of Immune Cells Could Fight Alzheimer’s

March 2015

Alzheimer’s Advocate vol. 84

FDA Commissioner Hamburg Addresses Budget and Medical Innovation

FDA to Hold Workshops on Endpoints and Regulatory Science

U.K. Government Announces Creation of Dementia Discovery Fund

Simple Blood Test Could Detect Beta Amyloid Proteins, Say Experts

16-Year-Old’s Alzheimer’s Device Featured at White House Science Fair

New Novel Approach to Treating Inherited Alzheimer’s Explored by Experts

Website Offers Comprehensive Info for Alzheimer’s Prevention Research

April 2015

Alzheimer’s Advocate vol. 85

ACT-AD Holds Webinar on Novel Targets for AD Treatment

ACT-AD Calls for $200 Million Increase in FY 2016 Appropriated Funding for FDA

NIA Seeks Volunteers for Alzheimer’s Disease Clinical Trials

ACT-AD Science Advisory Board Member Dr. Reisa Sperling and A4 Study Featured in Prevention Magazine

Senate Committee Hearings on Innovation Continue

NIH Puts Focus on Alzheimer’s Disease

MIND Diet May Reduce Risk of AD

Cancer Drug May Offer Hope to Alzheimer’s Disease Patients

Deprivation of Nutrient Arginine Could Cause AD

May 2015

Alzheimer’s Advocate vol. 86

ACT-AD Offers Comment on 21st Century Cures Bill

ICYMI: ACT-AD Webinar on Novel Targets for AD Treatment Available

Recommendations on NIH Summit Released

ACT-AD To Take Part in BIO International Convention

New Report on International Forum to Advance AD
Research Released

Peptide D8 Offers Potential Early Intervention
for Alzheimer’s Disease

Aspiring Scientist Takes on AD

Comprehensive New Study on Cognitive Aging Released

A Connection between AD and Diabetes?

June 2015

Alzheimer’s Advocate vol. 87

SAVE THE DATE: ACT-AD FDA/AD Allies Meeting Set for September 16

ACT-AD Part of Two Sessions at BIO Convention

ACT-AD’s Bens to Participate in FDA PDUFA July 15 Meeting

New Report Covers Role of Caregiver in the U.S.

Impact Factor of Journal of Alzheimer’s Disease Increases 15 Percent

Treatment That Protects Against Organ Transplant Rejection May Also Protect Against AD

Amyloid Precursor Protein May Play Role in Eye and Muscle Health

July 2015

Alzheimer’s Advocate vol. 88

ACT-AD Executive Director Testifies at Key FDA Meetings

SAVE THE DATE: ACT-AD FDA/AD Allies Meeting Set for September 16

Alzheimer’s Association International Conference Held This Month

ACT-AD Member to Host 16th International Conference on Alzheimer’s Drug Discovery

FDA Report on Collaboration and Research Needed to Develop Cures

An Update on Policy of Use of Single IRB for Multisite Research

August 2015

Alzheimer’s Advocate vol. 89

Register Now for the ACT-AD FDA/AD Allies Meeting!

ACT-AD Executive Director Speaks at PDUFA Briefing on September 2

ACT-AD Member Hosts International Conference on Alzheimer’s Drug Discovery, October 5-6

An Examination of Medical Costs Due to AD Misdiagnosis among Medicare Beneficiaries

Experts ID Risk Factors That May Lead to Development of AD

MIND Diet May Slow Cognitive Decline, Say Researchers

Study Finds Age Affects the Brain’s Ability to Dispose of Amyloid Beta Protein

September 2015

Alzheimer’s Advocate vol. 90

ACT-AD Eighth Annual Meeting a Great Success

New Resource from the Alzheimer’s Foundation of America

FDA Holds PDUFA Stakeholder Meeting

AD Clinical Trials Enroll First Patient

Alzheimer’s Researcher Tanzi Honored by Alliance for Aging Research

New Study Finds Alzheimer’s Disease Composed of Three Distinct Subtypes

Researchers Seek to Find Brain’s Progression to Dementia

October 2015

Alzheimer’s Advocate vol. 91

ICYMI: ACT-AD’s FDA/AD Allies Meeting Recap

Status of FY 2016 FDA Funding Still Up in the Air

Updates on PDUFA and MDUFA

FDA Updates Report on Areas of Progress and Continuing Challenges

New Members Added to HHS Alzheimer’s Advisory Council

AFA Holds Auction to Raise Awareness about Programs

Expert Tanzi Talks Alzheimer’s Research

Experts Make Discovery into the Role of Microglia in Development of AD

The Promise of Small Heat Shock Proteins

November 2015

Alzheimer’s Advocate vol. 92

Senate Committee Considers FDA Commissioner Nomination

FDA Hosts Workshop on Neurodiagnostics

FDA Continues Monthly Stakeholder Consultation on PDUFA and MDUFA

Conference on Alzheimer’s Disease-Related Dementias, March 29-30, 2016

New Paper on ‘Current Dementia R&D Landscape’

NIH Starts Initiative on Alzheimer’s Disease and Down Syndrome

November 1-7 Was National Memory Screening Week

New Infographic on the Impact of Alzheimer’s Disease Research

Experts Say Immune System in Brain Could Help Remove Amyloid Plaques

December 2015

Alzheimer’s Advocate vol. 93

Congress Passes FY 2016 Appropriations Bill, Good News for Alzheimer’s Disease Research

Stakeholder Consultation on FDA User Fee Reauthorization Continues, ACT-AD Represented

ACT-AD Executive Director Joins Panel on FDA and Patient Centeredness

NIA Releases Alzheimer’s Disease Progress Report

New Study Finds Anti-Androgen Drugs Could Be Linked to Increased Alzheimer’s Disease Risk

Experts Examine Connection between Gait Speed and Alzheimer’s Disease

Negative Beliefs about Aging Could Contribute to Development of Alzheimer’s Disease, Say Yale Experts

January 2016

Alzheimer’s Advocate vol. 94

Save-the-Date: ACT-AD Webinar on Personalized Medicine

FDA Workshop to Gather Perspectives on Genetic Testing

ACT-AD a Media Partner for 10th Annual Drug Discovery Conference

How Will Alzheimer’s Disease Impact China?

ACT-AD Welcomes New Member, APOE4.Info, Inc.

Alzheimer’s Disease-Related Dementias 2016 Summit Set for March 29-30

Experts Say Urine Test Could Potentially Predict AD

February 2016

Alzheimer’s Advocate vol. 95

Don’t Miss ACT-AD’s Webinar on Personalized Medicine

New Study Suggests Incidence of Dementia May Be Declining

Experts ID Part of the Brain That May Be First Impacted by Alzheimer’s Disease Onset

Bill to Create Alzheimer’s Stamp Introduced in House


March 2016

Alzheimer’s Advocate vol. 96

Save the Date for ACT-AD’s Ninth Annual FDA/AD Allies Meeting/November 16

ACT-AD Submits Letter Calling for Increased Funding for FDA

ACT-AD’s Bens to Speak at CDER Event on March 31

AHRQ Releases New Report on Dementia and Nonpharmacologic Interventions

Researchers Say PET Scans Can Track Progressive Stages of AD for the First Time

Upcoming PBS Special Focuses on Alzheimer’s Disease

FDA Issues Draft Guidance Request on Neurological Devices

NIH Launches Consortium to Study Vascular Links to AD

CIBR Medical Technology Showcase Set for April 12

New Dementia Care Plan Tool Launches

New Film Looks at a Condition Called PseudoBulbar Affect

April 2016

Alzheimer’s Advocate vol. 97

Webinar on Personalized Medicine and Alzheimer’s Disease Now Available

Save the Date for ACT-AD’s Ninth Annual FDA/AD Allies Meeting/November 16

Researchers Explore Role of Microglia in Alzheimer’s Disease

LEAD Coalition Looking for Communications & Advocacy Director

ICYMI: PBS Special Focuses on Alzheimer’s Disease

May 2016

Alzheimer’s Advocate vol. 98

Senate Committee Acts on Fiscal Year 2017 FDA Appropriations

Prospects Are Promising for Innovation Legislation

Save the Date for ACT-AD’s Ninth Annual FDA/AD Allies Meeting/November 16

Could Tau Proteins Offer Early Warning of Memory Loss?

Finding Could Provide New Insights about Alzheimer’s Disease